mobile menu
business
AU & NZ ENTERPRISE PROFILES

Antisense Therapeutics Limited - Australian Company Profile

Enterprise Type: Public Company

ASX Code: ANP

What does Antisense Therapeutics Limited do?

Antisense Therapeutics Limited is a locally owned publicly listed company, engaged in the research and development of novel antisense pharmaceuticals. The company operates in Australia, and is administered from its head office in Toorak, Victoria.

The company is listed on the Australian Securities Exchange under the code, ANP. The company is also listed on the Frankfurt Stock Exchange under the ticker code AWY, and the American Depository Receipts under the code OTC:ATHJY.

Antisense Therapeutics Limited - Products & Brands

Antisense Therapeutics Limited is an ASX listed biotechnology company. The company is engaged in the development of the following products:

  • ATL1102 – The company is conducting clinical trials of ATL1102 for the treatment of Duchenne Muscular Dystrophy and Multiple Sclerosis.
  • ATL1103 – The company is conducting clinical trials of ATL1103 for the treatment of Acromegaly.

Antisense Therapeutics also have a partnership with Ionis Pharmaceuticals Inc for its antisense drugs.

IBISWorld provides enterprise profiles on thousands of leading organizations across Australia and New Zealand.

LEARN MORE

Antisense Therapeutics Limited - Financial Statements

pie_chart Antisense Therapeutics Limited Financial Profit & Loss Account

BALANCE DATE6/30/20226/30/20216/30/20206/30/20196/30/2018
Sales RevenueN/AN/AN/AN/AN/A
Other Revenue0000000000000000000000000
Total Revenue0000000000000000000000000
Cost of Goods Sold0000000000000000000000000
Depreciation0000000000000000000000000
R & D Expenditure0000000000000000000000000
lock To view Antisense Therapeutics Limited's full competitive environment, see report purchase options.
Purchase this report or a membership to unlock the full analysis of the capital intensity of this industry.

Antisense Therapeutics Limited - Financial Ratios

pie_chart Antisense Therapeutics Limited Financial Growth

BALANCE DATE6/30/20226/30/20216/30/20206/30/20196/30/2018
Total Revenue Growth184.45-17.4818.22119.12-44.71
Sales Revenue Growth0000000000000000000000000
EBITDA0000000000000000000000000
NPAT0000000000000000000000000
Shareholder's Funds0000000000000000000000000
AAAAAA AAAAAA0000000000000000000000000

pie_chart Antisense Therapeutics Limited Financial Ratios

BALANCE DATE6/30/20226/30/20216/30/20206/30/20196/30/2018
Return on Revenue (ROR) (%)-320.8-1265.5-765.3-450.8-782.2
Return on Shareholders’ Funds (ROSF) (%)0000000000000000000000000
Return on Assets (ROA) (%)0000000000000000000000000
Profit Margin (%)0000000000000000000000000
Revenue per Employee ($’000 per person)0000000000000000000000000
AAAAAA AAAAAA0000000000000000000000000
lock To view Antisense Therapeutics Limited's full competitive environment, see report purchase options.
Purchase this report or a membership to unlock the full analysis of the capital intensity of this industry.

Antisense Therapeutics Limited's Competitive Environment

Antisense Therapeutics Limited operates in the following industries:

Antisense Therapeutics Limited's main competitors:

  • QLD Department of Education
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
lock To view Antisense Therapeutics Limited's full competitive environment, see report purchase options.
Purchase this report or a membership to unlock the full analysis of the capital intensity of this industry.

Looking for IBISWorld Industry Reports?

Gain strategic insight and analysis on 700+ Australian industries
(& thousands of global industries)

Enterprise Profiles - table of contents

Enterprise Details

Get a high-level overview of Antisense Therapeutics Limited, including registered business details, an enterprise synopsis, SWOT analysis and main brands and products.

Key Personnel

We outline the key personnel at Antisense Therapeutics Limited by position type and title.

Enterprise Financials

Get a full view of Antisense Therapeutics Limited’s financials, including Profit and Loss Account (Revenue, Interest, Profit and Loss, and Audit Fees) and Balance Sheet (Current Assets, Non-Current Assets, Current Liabilities, Non-Current Liabilities, Shareholders’ Equity), as well as Number of Employees, Number of Share on Issue, Market Capitalisation and Earnings per Share where available. Note: we do not provide a full financial details for all company profiles.

Growth & Ratios

Get a clearer picture of Antisense Therapeutics Limited’s performance, with key financial ratios and data on financial growth.

Operating Segments

Understand the main operating divisions of Antisense Therapeutics Limited, including Revenue and Assets under each Segment, Industries and Geographic Locations Antisense Therapeutics Limited operates in.

Competitor Benchmarking

Compare Antisense Therapeutics Limited’s financial ratios and growth to peers in their industries of operation for a clearer picture of performance.

Major Shareholders

We outline the ultimate parent and largest shareholders of Antisense Therapeutics Limited.

Subsidiaries

View a list of Antisense Therapeutics Limited’s associated companies, holding company, joint ventures and trusts, both domestic and international.

History

Find out more about the history and background of Antisense Therapeutics Limited, including founding information, past announcements, mergers and major projects.

Purchase to Read Full Report

100% Money Back Guarantee Digicert Trusted

Included in Report

  • Enterprise History & Synopsis
    Enterprise History & Synopsis
  • Enterprise Financial Statements
    Enterprise Financial Statements
  • Financial Ratios
    Financial Ratios
  • Industry Averages
    Industry Averages
  • Competitive Landscape
    Competitive Landscape
  • Key Enterprise Personnel
    Key Enterprise Personnel
  • Subsidiaries & Ownership Structure
    Subsidiaries & Ownership Structure

Why buy this enterprise profile on Antisense Therapeutics Limited?

IBISWorld enterprise profiles enable you to:

  • Understand a enterprise’s competitive landscape
  • Identify industry trends a enterprise is exposed to
  • Inform your decisions for marketing, strategy and planning
  • Target key enterprise personnel

The profile on Antisense Therapeutics Limited includes:

  • Enterprise History and Synopsis
  • Overview of Brands and Products
  • Enterprise Financial Statements and Financial Ratios
  • Key Enterprise Personnel
  • Subsidiaries, Shareholders and Ownership Structure
  • Service Providers

IBISWorld provides profiles on thousands of leading enterprises across Australia and New Zealand, as well as reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on business and industry trends. Our expert reports are thoroughly researched, reliable and current, enabling you to make faster, better business decisions.

Trusted by More Than 10,000 Clients Around the World

  • IBISWorld client - VISA
  • IBISWorld client - ADP
  • IBISWorld client - Deloitte
  • IBISWorld client - AMEX
  • IBISWorld client - Bank of Montreal